Philip J. Tofilon

ORCID: 0000-0003-0170-1194
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • DNA Repair Mechanisms
  • PI3K/AKT/mTOR signaling in cancer
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Histone Deacetylase Inhibitors Research
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • Carcinogens and Genotoxicity Assessment
  • Cancer, Hypoxia, and Metabolism
  • Molecular Biology Techniques and Applications
  • Effects of Radiation Exposure
  • Cancer Cells and Metastasis
  • ATP Synthase and ATPases Research
  • Cancer Research and Treatments
  • Radiopharmaceutical Chemistry and Applications
  • MicroRNA in disease regulation
  • Cancer-related molecular mechanisms research
  • DNA and Nucleic Acid Chemistry
  • Cancer-related Molecular Pathways
  • Heat shock proteins research
  • Chemical Reactions and Isotopes
  • PARP inhibition in cancer therapy
  • Brain Metastases and Treatment
  • Protein Degradation and Inhibitors

National Cancer Institute
2016-2025

National Institutes of Health
2013-2025

Advanced Radiation Therapy (United States)
2023

Center for Cancer Research
2003-2023

University of California, San Diego
2023

University of South Florida
2006-2013

Brown University
2013

Augusta University
2012

Emory University
2012

Moffitt Cancer Center
2006-2011

Exosomes are nanometer-sized lipid vesicles released ubiquitously by cells, which have been shown to a normal physiological role, as well influence the tumor microenvironment and aid metastasis. Recent studies highlight ability of exosomes convey tumor-suppressive oncogenic mRNAs, microRNAs, proteins receiving cell, subsequently activating downstream signaling pathways influencing cellular phenotype. Here, we show that radiation increases abundance glioblastoma cells astrocytes. derived from...

10.1593/tlo.13640 article EN cc-by-nc-nd Translational Oncology 2013-12-01

Object. To overcome the problems associated with using stereotactic techniques to establish intracranial xenografts in nude mice and treat engrafted tumors intratumoral therapies (such as gene or viral therapies), authors developed an implantable guide-screw system. In this study, they describe system, its method of implantation, their experience establishing delivering therapy. Methods. The system consists a 2.6-mm guide screw central 0.5-mm diameter hole that accepts 26-gauge needle...

10.3171/jns.2000.92.2.0326 article EN Journal of neurosurgery 2000-02-01

Abstract In vitro investigations of tumor stem-like cells (TSC) isolated from human glioblastoma (GB) surgical specimens have been done primarily at an atmospheric oxygen level 20%. To determine whether more consistent with in situ conditions affects their stem cell–like characteristics, we compared GB TSCs grown under 20% and 7% oxygen. Growing CD133+ sorted three neurosphere cultures O2 reduced doubling time increased the self-renewal potential as reflected by clonogenicity. Furthermore,...

10.1158/1541-7786.mcr-08-0360 article EN Molecular Cancer Research 2009-04-01

Prostaglandins are arachidonate metabolites produced in virtually all mammalian tissues and possess diverse biologic capabilities, including vasoconstriction, vasodilatation, stimulation or inhibition of platelet aggregation, immunomodulation, primarily immunosupression (1–4). They implicated the promotion development growth malignant tumors (4–7). also involved response tumor normal to cytotoxic agents such as ionizing radiation (8). Prostaglandin production is mediated by two...

10.1093/jnci/91.17.1501 article EN JNCI Journal of the National Cancer Institute 1999-09-01

Abstract Histone deacetylase (HDAC) inhibitors are undergoing clinical evaluation for cancer therapy. Because HDAC modulates chromatin structure and gene expression, parameters considered to influence radioresponse, we have investigated the effects of inhibitor MS-275 on radiosensitivity two human tumor cell lines (DU145 prostate carcinoma U251 glioma). Acetylation status histones H3 H4 was determined as a function time after addition removal from culture medium. acetylation increased by 6 h...

10.1158/0008-5472.can-03-2630 article EN Cancer Research 2004-01-01

Valproic acid (VA) is a well-tolerated drug used to treat seizure disorders and has recently been shown inhibit histone deacetylase (HDAC). Because HDAC modulates chromatin structure gene expression, parameters considered influence radioresponse, we investigated the effects of VA on radiosensitivity human brain tumor cells grown in vitro vivo. The cell lines SF539 U251 were our study. Histone hyperacetylation served as an indicator inhibition. assessed using clonogenic survival assay...

10.1002/ijc.20774 article EN International Journal of Cancer 2004-12-01

Abstract Purpose: CD133+ glioblastoma tumor stem-like cells (TSC) have been defined as radioresistant. However, although previously classified relative to CD133− cells, the radiosensitivity of TSCs with respect standard model, established glioma cell lines, has not determined. Therefore, better understand radioresponse this cancer stem cell, we used lines a framework for defining their in vitro radioresponse. Experimental Design: The intrinsic TSC cultures and was determined by clonogenic...

10.1158/1078-0432.ccr-09-0263 article EN Clinical Cancer Research 2009-08-12

Abstract Purpose: Poly (ADP-ribose) polymerase (PARP) inhibitors are undergoing clinical evaluation for cancer therapy. Because PARP inhibition has been shown to enhance tumor cell sensitivity radiation, we investigated the in vitro and vivo effects of novel inhibitor E7016. Experimental Design: The effect E7016 on radiosensitivity lines was evaluated using clonogenic survival. DNA damage repair were measured γH2AX foci neutral comet assay. Mitotic catastrophe determined by immunostaining....

10.1158/1078-0432.ccr-08-2079 article EN Clinical Cancer Research 2009-01-15

Brain tumor xenografts initiated from glioblastoma (GBM) CD133+ stem-like cells (TSCs) are composed of TSC and non-TSC subpopulations, simulating the phenotypic heterogeneity GBMs in situ. Given that discrepancies between radiosensitivity GBM vitro treatment response patients suggest a role for microenvironment radioresistance, we compared TSCs non-TSCs irradiated under orthotopic conditions. As measure radioresponse determined at individual cell level, γH2AX 53BP1 foci were quantified their...

10.1593/neo.111794 article EN cc-by-nc-nd Neoplasia 2012-02-01

Glioblastomas (GBMs) are characterized as highly invasive; the contribution of GBM stem-like cells (GSCs) to invasive phenotype, however, has not been completely defined. Towards this end, we have defined invasion potential CD133+ GSCs and their differentiated CD133− counterparts grown under standard in vitro conditions co-culture with astrocytes. Using a trans-well assay, astrocytes or astrocyte conditioned media bottom chamber significantly increased yet had no effect on cells. In...

10.1371/journal.pone.0054752 article EN cc-by PLoS ONE 2013-01-22

Abstract Radiotherapy is a primary treatment modality for glioblastomas (GBM). Because DNA-PKcs critical factor in the repair of radiation-induced double strand breaks (DSB), this study evaluated potential VX-984, new inhibitor, to enhance radiosensitivity GBM cells. Treatment established cell line U251 and stem-like (GSC) NSC11 with VX-984 under vitro conditions resulted concentration-dependent inhibition phosphorylation. In similar manner, enhanced each as defined by clonogenic analysis....

10.1158/1535-7163.mct-17-1267 article EN Molecular Cancer Therapeutics 2018-03-16

Inhibitors of the molecular chaperone Hsp90 have been shown to enhance tumor cell radiosensitivity. To begin address mechanism responsible, we determined effect inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17DMAG) on DNA damage response radiation. Exposure MiaPaCa cells 17DMAG, which results in radiosensitization, inhibited repair double-strand breaks according gammaH2AX foci dispersal and neutral comet assay. This inhibition was associated with reduced DNA-PK catalytic...

10.1158/0008-5472.can-06-2181 article EN Cancer Research 2006-09-15

Histone deacetylase (HDAC) inhibitors are undergoing clinical evaluation in cancer therapy. Because HDAC modulation has been shown to enhance the radiosensitivity of tumor cells vitro, we investigated effects inhibitor MS-275 on radioresponse DU145 prostate carcinoma xenografts.As an indicator inhibition vivo, histone acetylation status lysates was determined after two, four, and six injections delivered at 12-hour intervals, as well 24 48 hours last injection. Tumor growth delay studies...

10.1158/1078-0432.ccr-04-0537 article EN Clinical Cancer Research 2004-09-15

Abstract Vascular endothelial growth factor (VEGF) is an cell‐specific mitogen, which also enhances vascular permeability. Because this angiogenic has been suggested to play a role in brain tumor biology, we have begun investigate the regulation of VEGF expression cultures rat type I astrocytes. In report, focused on influence hypoxia expression. Under standard vitro conditions (21% O 2 ) astrocytes barely detectable by northern analysis. However, after exposure 0.2% for as little 3 h mRNA...

10.1002/glia.440140203 article EN Glia 1995-06-01

Although ionizing radiation has been shown to influence gene transcription, little is known about the effects of on translational efficiency. To obtain a genome-wide perspective translation, microarray analysis was done polysome-bound RNA isolated from irradiated human brain tumor cells; allow for comparison with also using total RNA. The number genes whose activity modified by approximately 10-fold greater than those transcription affected. radiation-induced change in gene's involve...

10.1158/0008-5472.can-05-3459 article EN Cancer Research 2006-01-15

Abstract Purpose: Temozolomide, a DNA methylating agent, is currently undergoing clinical evaluation for cancer therapy. Because temozolomide has been shown to increase survival rates of patients with malignant gliomas when given combined radiation, and there conflicting preclinical data concerning the radiosensitizing effects temozolomide, we further investigated possible temozolomide-induced enhancement radiosensitivity. Experimental Design: The on in vitro radiosensitivity U251 (a human...

10.1158/1078-0432.ccr-07-1856 article EN Clinical Cancer Research 2008-02-01
Coming Soon ...